MORPOSYS AND ROCHE EXPAND THERAPEUTIC ANTIBODY PARTNERSHIP

MorphoSys AG and Roche today announced a collaboration to develop new therapeutic antibodies in oncology. Expanding on a September 2000 relationship in Alzheimer's disease, Roche will elect new target molecules against which MorphoSys will generate antibodies using its proprietary HuCAL GOLD technology.
WebWire